Author:
Kessler-Zumpe P.L.,Murgas S.,Neumann G.,Richter A.E.
Publisher
Springer Science and Business Media LLC
Reference12 articles.
1. Alloussi S, Goepel M, Richter AE et al (2005) Therapie der Detrusorhyperaktivität mit Propiverin. Urologe A 44:382–386
2. Alloussi S, Schönberger B, Mürtz G et al (2000) Behandlung des Urge-Syndroms mit Propiverin in der therapeutischen Praxis. Urologe B 40:367–373
3. Claxton AJ, Cramer J, Pierce C (2001) A systematic review of the associations between dose regimes and medication compliance. Clin Ther 23:1296–1310
4. Gramatte T, Gruber P, Güldner P et al (2002) Oral dosage form for propiverine or its pharmaceutically acceptable salts with an extended release of the active ingredient. WO 03/030869 A1
5. Höfner K, Burkart M, Jacob G, Jonas U (2007) Safety and efficacy of tolterodine extended release in men with overactive bladder symptoms and presumed non-obstructive benign prostatic hyperplasia. World J Urol 25:627–633
Cited by
5 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献